Yohei Yamamoto

Komae, 2018601, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma.

Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma.

Journal: Journal of neuro-oncology

Published: June 17, 2026

Catheter-tract recurrence after Ommaya reservoir-assisted cyst decompression followed by stereotactic radiosurgery for cystic brain metastasis: A case report.

Catheter-tract recurrence after Ommaya reservoir-assisted cyst decompression followed by stereotactic radiosurgery for cystic brain metastasis: A case report.

Journal: Surgical neurology international

Published: May 10, 2026

Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching.

Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching.

Journal: Cancers

Published: January 13, 2026

Multilayer dural repair using absorbable artificial dura in the posterior fossa: A case report on the "sandwich technique".

Multilayer dural repair using absorbable artificial dura in the posterior fossa: A case report on the "sandwich technique".

Journal: Surgical neurology international

Published: September 02, 2025

Alteration of Prognostic Factors for Patients with Brain Metastases from Lung Cancer Before and After the Introduction of Immune Checkpoint Inhibitors: A Retrospective Single-Institution Study.

Alteration of Prognostic Factors for Patients with Brain Metastases from Lung Cancer Before and After the Introduction of Immune Checkpoint Inhibitors: A Retrospective Single-Institution Study.

Journal: Cancers

Published: July 22, 2025

Validation of a prognostic scoring system for brain metastases with synchronous detection of primary cancers at initial consultation.

Validation of a prognostic scoring system for brain metastases with synchronous detection of primary cancers at initial consultation.

Journal: Frontiers in oncology

Published: April 24, 2025

Significance and Priority of Surgical Resection as Therapeutic Strategy Based on Clinical Characteristics of Brain Metastases from Renal Cell Carcinoma.

Significance and Priority of Surgical Resection as Therapeutic Strategy Based on Clinical Characteristics of Brain Metastases from Renal Cell Carcinoma.

Journal: World neurosurgery

Published: August 25, 2024

Comparative analyses of erythroblast transformation specific-1 related gene expression before and after neoadjuvant bevacizumab therapy for newly diagnosed glioblastoma.

Comparative analyses of erythroblast transformation specific-1 related gene expression before and after neoadjuvant bevacizumab therapy for newly diagnosed glioblastoma.

Journal: International journal of clinical and experimental pathology

Published: June 09, 2024

Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.

Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.

Journal: Brain tumor pathology

Published: May 07, 2024

Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma.

Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma.

Journal: Brain tumor pathology

Published: February 24, 2024

Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.

Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.

Journal: Brain tumor pathology

Published: October 20, 2023

An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.

An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.

Journal: Journal of neuro-oncology

Published: July 31, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026